[Immunogenicity of cancer-associated and cancer-specific antigens]
- PMID: 6927369
[Immunogenicity of cancer-associated and cancer-specific antigens]
Abstract
The immunogenicity and anti-tumor activity of tumor-specific and tumor-associated antigens (TSA and TAA) isolated from the Ehrlich ascites cancer (EAC) cell plasma membrane is assayed, and compared with the action of several crude antigenic preparations. Control animals die 26 days after the EAC cells inoculation. Crude antigenic preparations produce a delay of EAC development, but all the animals finally die. The purified TSA and TAA are active at very small amounts, and inhibit completely and permanently the tumor development. The procedure shows a new approach to cancer specific active immunotherapy.
Similar articles
-
[Method of isolation of cancer-associated and cancer-specific antigens].Rev Esp Oncol. 1982;29(4):675-84. Rev Esp Oncol. 1982. PMID: 6765421 Spanish.
-
[Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].Eksp Onkol. 1989;11(1):69-71. Eksp Onkol. 1989. PMID: 2466634 Russian.
-
[Study of indirect active immunotherapy of Ehrlich carcinoma].Rev Inst Antibiot (Recife). 1974 Dec;14(1-2):3-8. Rev Inst Antibiot (Recife). 1974. PMID: 4471334 Portuguese.
-
Antitumor vaccination: where we stand.Haematologica. 2000 Nov;85(11):1172-206. Haematologica. 2000. PMID: 11074658 Review.
-
Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.Anticancer Res. 1996 Mar-Apr;16(2):661-74. Anticancer Res. 1996. PMID: 8687112 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials